课题基金 / 基金详情

CAM KINASE II AND LEARNING AND MEMORY

CAM KINASE II AND LEARNING AND MEMORY
CAM 激酶 II 与学习和记忆
批准号:
6538325
负责人:
Rafael Bejar
金额:
$0.64万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
未结题
起止时间:
2002-07-01 至

项目摘要

项目成果

Rafael Bejar的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Adapted from applicant's abstract): The long-term objective of this research is to provide a clearer understanding of the molecular basis of synaptic plasticity and how this relates to learning, memory, and behavior. This is an important health-related issue because abnormal neuronal function has been implicated in the pathoetiology of several diseases including psychiatric disorders, ischemic brain injury, and Alzheimer's disease. This line of research is also relevant to age-related changes in memory function. We propose to study the mechanisms through which an overexpressed Ca2+-independent form of calmodulin-dependent kinase II (CaMKII-Asp286) disrupts both synaptic plasticity in the hippocampus and behavioral performance on spatial memory-dependent tasks. Our specific aims are (1) to determine whether calmodulin trapping by CaMKII-Asp286 is sufficient to produce the physiological and behavioral phenotype observed in mice expressing this Ca2+-independent form of CaMKII, (2) to determine if disruption of synaptic plasticity by CaMKII-Asp286 in the CA1 region of the hippocampus alone is sufficient to produce a deficit in spatial learning and memory, and (3) to identify which stage of learning and memory, either acquisition, consolidation, or recall, is sensitive to disruption by expression of the CaMKII-Asp286 transgene. These aims will be accomplished by studying the activity of CaMKII-Asp286 in vitro, by creating two new lines of transgenic mice, and by testing these and existing transgenic animals on spatial tasks. First, we plan to create a line of mice carrying a Ca2+-independent form of CaMKII that has no kinase activity in order to determine if calmodulin trapping alone can create a phenotype similar to that seen in our existing mice. Using the CRE-lox system, we will create a second line of mice which expresses the CaMKII-Asp286 only in the CA1 region of the hippocampus. Finally, the existing mice we plan to study suppress CaMKII-Asp286 expression in response to tetracycline. This will allow us to regulate at which time after learning the transgene is expressed and is capable of disrupting spatial memory.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Characterization of Genetic Abnormalities in MDS and Their Clinical Impact
Characterization of Genetic Abnormalities in MDS and Their Clinical Impact
Characterization of Genetic Abnormalities in MDS and Their Clinical Impact
Characterization of Genetic Abnormalities in MDS and Their Clinical Impact
  • 批准号:
    8242386
  • 项目类别:
  • 资助金额:
    $3.67万
  • 财政年份:
    2012
  • 负责人:
    Rafael Bejar
  • 依托单位:
海外基金